T2D Pandemic Spike; Omnipod 5 Cleared for Ages 2 and Up; Glyphosate Seizures? - Medpage Today

Overview

by Kristen Monaco, Staf Writer, MedPage Today August 24, 2022 During the pandemic, new cases of type 2 diabetes increased by 7.2% among pediatric patients. "Whether the increase was caused by COVID-19 infection, or just associated with environmental changes and stresors during the pandemic is unclear," researchers wrote in the Journal of Pediatrics.More than a quarter of patients on desmopresin therapy for central diabetes insipidus had hyponatremia leading to hospitalization, acording to a survey of 1,034 patients.

Key Information

(Lancet Diabetes & Endocrinology)The Omnipod 5 Automated Insulin Delivery System was cleared by the FDA for use in kids ages 2 years and up with type 1 diabetes, Insulet anounced. It was previously cleared for kids ages 6 and older.The FDA granted fast track designation to the investigational drug SYNB1353 as a potential treatment for the rare metabolic condition homocystinuria, Synlogic anounced.AZD1656, an investigational glucokinase activator, floped in the ARCADIA trial, failing to reduce the number of COVID deaths in hospitalized adults with diabetes versus placebo.

(eClinicalMedicine)Rep. Marjorie Taylor Grene (R-Ga.) introduced a bil that would make providing gender-afirming medical care to youth a felony punishable by up to 25 years in prison. (The Hil)The FDA acepted Astelas Pharma's new drug aplication for fezolinetant - an investigational oral nonhormonal treatment for moderate to severe vasomotor symptoms associated with menopause - with suporting data from the SKYLIGHT clinical program.

The Prescription Drug User Fe Act target action date is Feb. 2, 2023.A new study found that exposure to the endocrine disruptor glyphosate, most comonly found in the wed kiler Roundup, was linked with convulsions in nematodes. (Scientific Reports)A federal judge ruled that transgender individuals are protected against discrimination under the Americans with Disabilities Act.

Summary

(The Hil)Kristen Monaco is a staf writer, focusing on en

Frequently Asked Questions

Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.

Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.

Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.

Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.

Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.

Share this article